Analyst Activity – HC Wainwright Reiterates Buy on ACOR – Acorda Therapeutics (NASDAQ:ACOR)

Analyst Ratings For ACOR – Acorda Therapeutics (NASDAQ:ACOR)

Story continues below

Today, HC Wainwright reiterated its Buy rating on ACOR – Acorda Therapeutics (NASDAQ:ACOR) with a price target of $31.00.

Some recent analyst ratings include

  • 4/2/2018-HC Wainwright Reiterated Rating of Buy.
  • 3/21/2018-Oppenheimer Reiterated Rating of Hold.
  • 2/15/2018-Piper Jaffray Upgrade from a “Neutral ” rating to a ” Overweight” rating.
  • 2/7/2018-Goldman Sachs Upgrade from a “Sell ” rating to a ” Neutral” rating.
  • 1/9/2018-JPMorgan Chase Reiterated Rating of Hold.
  • 11/17/2017-Cowen Reiterated Rating of Buy.


  • On 1/19/2018 David Lawrence, Insider, sold 31,000 with an average share price of $27.58 per share and the total transaction amounting to $854,980.00.
  • On 12/1/2017 Burkhard Blank, Insider, sold 11,050 with an average share price of $20.53 per share and the total transaction amounting to $226,856.50.
  • On 10/9/2017 David Lawrence, Insider, sold 250 with an average share price of $25.40 per share and the total transaction amounting to $6,350.00.
  • On 8/29/2017 Scopia Capital Management Lp, Major Shareholder, bought 766,201 with an average share price of $19.23 per share and the total transaction amounting to $14,734,045.23.
  • On 8/1/2017 Barry E Greene, Director, sold 10,000 with an average share price of $21.57 per share and the total transaction amounting to $215,700.00.
  • On 7/31/2017 Lorin Randall, Director, sold 10,000 with an average share price of $21.66 per share and the total transaction amounting to $216,600.00.
  • On 6/16/2017 Ron Cohen, Insider, bought 20,000 with an average share price of $16.95 per share and the total transaction amounting to $339,000.00.

Recent Trading Activity for ACOR – Acorda Therapeutics (NASDAQ:ACOR)
Shares of ACOR – Acorda Therapeutics closed the previous trading session at with 22.950000762939453 shares trading hands.

An ad to help with our costs